马文慧,于宝军,罗 丹,张丽丽,王 静

棘阿米巴感染性角膜炎是由棘阿米巴原虫引起的一种感染性角膜疾病。其主要症状包括畏光、视力减退以及剧烈眼痛。棘阿米巴原虫感染角膜后，会导致角膜炎症，增加眼部敏感性，从而产生畏光等相关临床症状。本个案主要描述使用角膜穿透移植术对一例棘阿米巴感染性角膜炎患者进行治疗的临床体会。该患者在收治之后使用前节相干光层析成像术和B超检查明确诊断为棘阿米巴感染性角膜炎，前期给予该例患者使用保守治疗，但是后期患者病程进展较快，累及近全角膜，遂行穿透性角膜移植术。术后患者的恢复十分理想并且没有出现病情复发。经证实，棘阿米巴感染性角膜炎确诊后应及时采取手术方式，以确保患者眼球的完整性，提升并改善患者的生活质量。

棘阿米巴感染性角膜炎；角膜穿透移植术；疗效；棘阿米巴原虫

[1]Clarke DW, Niederkorn JY. 2006. The pathophysiology of Acanthamoeba keratitis. Trends in Parasitology, 22(4), 175–180. [2]Tu EY, Joslin CE, Sugar J, Shoff ME, Booton GC. 2008. Prognostic factors affecting visual outcome in Acanthamoeba keratitis. Ophthalmology, 115, 1998–2003. [3]Villani E, Baudouin C, Efron N, Hamrah P, Kojima T, Patel SV, Pflugfelder SC, Zhivov A, Dogru M. 2014. In vivo confocal microscopy of the ocular surface: from bench to bedside. Current Eye Research, 39(3), 213–231. [4]Khan NA. 2009. Acanthamoeba – Biology and Pathogenesis. Caister Academic Press: Norfolk, Great Britain, 290 p. [5] Ren M, Gao L, Wu X. 2010. TLR4: the receptor bridging Acanthamoeba challenge and intracellular inflammatory responses in human corneal cell lines. Immunology and Cell Biology, 88, 529–536. [6]Chusattayanond AD, Boonsilp S, Kasisit J, Boonmee A, Warit S. 2010. Thai Acanthamoeba isolate (T4) induced apoptotic death in neuroblastoma cells via the Bax-mediated pathway.Parasitology International, 59, 512–516. [7]Michalek M, Sönnichsen FD, Wechselberger R, Dingley AJ, Hung CW, Kopp A, Wienk H, Simanski M, Herbst R, Lorenzen I, Marciano-Cabral F, Gelhaus C, Gutsmann T, Tholey A, Grötzinger J, Leippe M. 2013. Structure and function of a unique pore-forming protein from a pathogenic Acanthamoeba.Nature Chemical Biology, 9, 37–42. [8]Mazur T, Hadas E, Iwanicka I. 1995. The duration of the cyst stage and the viability and virulence of Acanthamoeba isolates.Tropical Medicine and Parasitology, 46, 106–108. [9]Khan NA. 2009. Acanthamoeba – Biology and Pathogenesis.Caister Academic Press: Norfolk, Great Britain, 290 p. [10]Lim N, Goh D, Bunce C, Xing W, Fraenkel G, Poole TR, Ficker L. 2008. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. American Journal of Ophthalmology, 145, 130–135. [11]Kandori M, Inoue T, Shimabukuro M, Hayashi H, Hori Y, Maeda N, Tano Y. 2010. Four cases of Acanthamoeba keratitis treated with phototherapeutic keratectomy. Cornea, 29(10), 1199–1202. [12]Khan YA, Kashiwabuchi RT, Martins SA, Castro-Combs JM, Kalyani S, Stanley P, Flikier D, Behrens A. 2011. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases.Ophthalmology, 118(2), 324–331.

点击下载PDF